Navigation Links
VMS BioMarketing Clinical Nurse Educators Will Provide Education to Support Needs of Women With Breast Cancer
Date:10/11/2017

INDIANAPOLIS, Oct. 11, 2017 /PRNewswire/ -- VMS BioMarketing, a leading provider of patient support solutions, has announced the development of a nationwide oncology Clinical Nurse Educator (CNE) network, which will launch this week. The VMS CNEs will address a growing need for communication among health care professionals to enhance the patient care experience by delivering peer-to-peer education programs to physicians, nurses, office staff, and other health care professionals to help women who have been diagnosed and are being treated for breast cancer.

VMS CNEs will deliver peer-to-peer education programs to physicians, nurses, office staff, and other healthcare professionals to help women who have been diagnosed and are being treated for breast cancer.
VMS CNEs will deliver peer-to-peer education programs to physicians, nurses, office staff, and other healthcare professionals to help women who have been diagnosed and are being treated for breast cancer.

According to the American Cancer Society, breast cancer is the most common cancer in American women, except for skin cancers. An estimated 252,710 women will be diagnosed with breast cancer this year, and 40,610 will die of the disease. Currently, the average risk of a woman in the United States developing breast cancer sometime in her life is about 12 percent 1

"Women who are affected by this devastating disease need physical, psychological, and emotional support," said Chris Field, director of strategic account management at VMS BioMarketing. "VMS is very pleased to provide additional education for health care professionals about treatments for breast cancer to help health care professionals, patients, and caregivers better understand the disease. Education will include how medication works, how and when to take their medication, what side effects if any to expect and how to manage them in their daily life, and how to connect with support resources patients need."

The CNEs in the VMS oncology educator network are highly specialized leaders in their field, with both clinical expertise in caring for people with chronic and life-threatening diseases as well as extensive skills in patient and provider education. In September, the field-based CNE team visited VMS BioMarketing in Indianapolis for onboarding, followed by online seminars. 

"The launch of this Clinical Nurse Educator network is particularly timely, as October is Breast Cancer Awareness Month," said Field. "VMS urges women to get regular screenings to find breast cancer early." The American Cancer Society has screening guidelines for women at average risk of breast cancer and for those at higher-than-average risk for breast cancer at the following link. https://www.cancer.org/healthy/find-cancer-early/cancer-screening-guidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer.html

About VMS BioMarketing:

VMS BioMarketing is a leading provider of patient support solutions focused on empowering health care providers and patients through education, training, and ongoing health coaching. For more than 20 years, VMS has been dedicated to enabling Clinical Nurse Educators to provide the personalized support necessary to help patients successfully start and stay on therapy. VMS clients include the world's leading pharmaceutical and biotechnology companies. To learn more, please visit www.vmsbiomarketing.com.

Contact:
Abigail Mallon  
317-805-6600, Ext. 225
Abigail.Mallon@vmsbiomarketing.com

1American Cancer Society. https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html

View original content with multimedia:http://www.prnewswire.com/news-releases/vms-biomarketing-clinical-nurse-educators-will-provide-education-to-support-needs-of-women-with-breast-cancer-300534822.html


'/>"/>
SOURCE VMS BioMarketing
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnologys CYT003 for the Treatment of Allergic Asthma
2. Positive Clinical Breast Cancer Data Presented for NuView’s Molecular Imaging Biomarker NLS-VPAC1
3. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
4. Ingenuity Systems and GeneInsight to Deliver an Interpretation and Reporting Workflow Solution to Clinical Laboratories
5. Greenwood Genetic Center Selects Cartagenia BENCHlab NGS, CNV Solutions for Clinical Data Analysis
6. Clinical Trials and Medical Research in Texas Create Jobs and Save Lives
7. Best Practices for Lean Six Sigma in Clinical Development and R&D, New Xtalks Life Sciences Webinar
8. Medical University of South Carolina Selects Elseviers Interdisciplinary Care Planning and Clinical Documentation Solution
9. Clinilabs Launches Research Volunteer Authentication Initiative Choosing Verified Clinical Trials to Stop Dual Enrollment in Clinical Trials
10. ISPE Releases New Guidance for Standardizing Use of Booklet Labels in Global Clinical Trials
11. Trigemina Receives ISP Approval of Clinical Study Protocol for TI-001 Phase 2 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... DuPont Pioneer and recently formed ... entered into a multiyear collaboration to identify and characterize novel CRISPR-Cas nucleases. The ... gene editing across all applications. , Under the terms of the agreement, Pioneer ...
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... ... 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. ... San Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, ... government officials from around the world to address key issues in device compliance, quality ...
(Date:10/11/2017)... ... ... Disappearing forests and increased emissions are the main causes of the evolving ... those living in larger cities are affected by air pollution related diseases. , That ... countries globally - decided to take action. , “I knew I had to take ...
Breaking Biology Technology:
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at VivaTech ... startups and global businesses, taking place in Paris ... will showcase the solutions they have built with IBM Watson ... France is one of the most dynamic ... in the number of startups created between 2012 and 2015*, ...
(Date:4/24/2017)... 2017 Janice Kephart , former ... Strategy Partners, LLP (IdSP) , today issues the ... Trump,s March 6, 2017 Executive Order: Protecting ... can be instilled with greater confidence, enabling the ... refugee applications are suspended by until at least ...
(Date:4/13/2017)... , April 13, 2017 According to a ... Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment ... the IAM Market is expected to grow from USD 14.30 Billion in ... Rate (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):